Literature DB >> 20519354

Lipoprotein subclass patterns in women with polycystic ovary syndrome (PCOS) compared with equally insulin-resistant women without PCOS.

N Phelan1, A O'Connor, T Kyaw-Tun, N Correia, G Boran, H M Roche, J Gibney.   

Abstract

OBJECTIVES: Women with polycystic ovary syndrome (PCOS) are more insulin resistant and display an atherogenic lipid profile compared with normal women of similar body mass index (BMI). Insulin resistance (IR) at least partially underlies the dyslipidemia of PCOS, but it is unclear whether PCOS status per se confers additional risk. RESEARCH DESIGN AND METHODS: Using a case-control design, we compared plasma lipids and lipoprotein subclasses (using polyacrylamide gel tube electrophoresis) in 70 women with PCOS (National Institutes of Health criteria) and 70 normal women pair matched for age, BMI, and IR (homeostasis model assessment-IR, quantitative insulin sensitivity check index, and the Avignon Index). Subjects were identified as having a (less atherogenic) type A pattern consisting predominantly of large low-density lipoprotein (LDL) subfractions or a (more atherogenic) non-A pattern consisting predominantly of small-dense LDL subfractions.
RESULTS: Total, high-density lipoprotein, or LDL cholesterol, or triacylglycerol did not differ between the groups, but very low-density lipoprotein levels (P<0.05) were greater in women with PCOS, whereas a non-A LDL profile was seen in 12.9% compared with 2.9% of controls (P<0.05, chi2). Multiple regression analysis revealed homeostasis model assessment-IR and waist circumference to be independent predictors of very low-density lipoprotein together explaining 40.2% of the overall variance. Logistic regression revealed PCOS status to be the only independent determinant of a non-A LDL pattern (odds ratio 5.48 (95% confidence interval 1.082-27.77; P<0.05).
CONCLUSIONS: Compared with women matched for BMI and IR, women with PCOS have potentially important differences in lipid profile with greater very low-density lipoprotein levels and increased rates of a more atherogenic non-A LDL pattern.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20519354     DOI: 10.1210/jc.2009-2444

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

1.  Testosterone and progesterone, but not estradiol, stimulate muscle protein synthesis in postmenopausal women.

Authors:  Gordon I Smith; Jun Yoshino; Dominic N Reeds; David Bradley; Rachel E Burrows; Henry D Heisey; Anna C Moseley; Bettina Mittendorfer
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

2.  Distinguishing characteristics of metabolically healthy versus metabolically unhealthy obese adolescent girls with polycystic ovary syndrome.

Authors:  Joon Young Kim; Hala Tfayli; Sara F Michaliszyn; Sojung Lee; Silva Arslanian
Journal:  Fertil Steril       Date:  2016-02-24       Impact factor: 7.329

Review 3.  Targets to treat metabolic syndrome in polycystic ovary syndrome.

Authors:  Shruthi Mahalingaiah; Evanthia Diamanti-Kandarakis
Journal:  Expert Opin Ther Targets       Date:  2015-10-21       Impact factor: 6.902

4.  Trends in serum lipids and hypertension prevalence among non-pregnant reproductive-age women: United States National Health and Nutrition Examination Survey 1999-2008.

Authors:  Tabassum H Laz; Mahbubur Rahman; Abbey B Berenson
Journal:  Matern Child Health J       Date:  2013-10

5.  Lipoprotein Particles in Adolescents and Young Women With PCOS Provide Insights Into Their Cardiovascular Risk.

Authors:  E Gourgari; M Lodish; R Shamburek; M Keil; R Wesley; M Walter; M Sampson; S Bernstein; D Khurana; C Lyssikatos; S Ten; A Dobs; A T Remaley; C A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2015-09-15       Impact factor: 5.958

6.  Cholesterol screening for women: who is "at-risk"?

Authors:  Cheryl L Robbins; Patricia M Dietz; Shanna Cox; Elena V Kuklina
Journal:  J Womens Health (Larchmt)       Date:  2013-04-26       Impact factor: 2.681

7.  Testosterone increases the muscle protein synthesis rate but does not affect very-low-density lipoprotein metabolism in obese premenopausal women.

Authors:  Xuewen Wang; Gordon I Smith; Bruce W Patterson; Dominic N Reeds; Janine Kampelman; Faidon Magkos; Bettina Mittendorfer
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-01-17       Impact factor: 4.310

8.  Decreased cholesterol efflux capacity and atherogenic lipid profile in young women with PCOS.

Authors:  Andrea Roe; Jennifer Hillman; Samantha Butts; Mathew Smith; Daniel Rader; Martin Playford; Nehal N Mehta; Anuja Dokras
Journal:  J Clin Endocrinol Metab       Date:  2014-02-10       Impact factor: 5.958

Review 9.  Lifestyle interventions for hypertension and dyslipidemia among women of reproductive age.

Authors:  Cheryl L Robbins; Patricia M Dietz; Jennifer Bombard; Michelle Tregear; Steven M Schmidt; Stephen J Tregear
Journal:  Prev Chronic Dis       Date:  2011-10-17       Impact factor: 2.830

Review 10.  Dyslipidemia in women with polycystic ovary syndrome.

Authors:  Jin Ju Kim; Young Min Choi
Journal:  Obstet Gynecol Sci       Date:  2013-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.